J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
Bernstein Remains a Buy on GlaxoSmithKline (GSK)
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
LONDON BRIEFING: Next ups guidance after strong Christmas trade
Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Both batches of data will be scrutinised for what they could mean for the European Central ...
labiotech6d
A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development
GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.